Saturday, July 5, 2025
HomeIndustriesBiotechnology

Biotechnology

Amyris Closes Acquisition of Menolabs

Amyris, Inc., a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform announced that it has closed...

Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics, Inc.,...

Insightec Receives FDA IDE Approval and “Breakthrough” Designation for NSCLC Brain Mets Study and Ide Approval for Liquid Biopsy Study

Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, announced that it has received FDA approval of two pivotal...

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

Antengene Corporation Limited, a leading innovative commercial stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and...

OnQuality Pharmaceuticals to Present Preclinical Data for OQL051, a Novel Chemotherapy-Induced Diarrhea Therapeutic, at AACR

OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in oncodermatology and oncogastroenterology (cancer therapy-induced side effects...
0FansLike
0FollowersFollow
spot_img

Hot Topics